Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,490 | -4,103 | -5,767 | -10,900 | 920 |
| Depreciation Amortization | N/A | 1,956 | 2,350 | N/A | N/A |
| Other Working Capital | N/A | -2,291 | 2,718 | N/A | N/A |
| Other Operating Activity | 10,670 | -2,015 | 279 | 12,070 | -220 |
| Operating Cash Flow | $-3,820 | $-6,453 | $-420 | $1,170 | $700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -536 | -90 | N/A | N/A |
| Other Investing Activity | -390 | 2,005 | 330 | -1,760 | -3,640 |
| Investing Cash Flow | $-390 | $1,469 | $240 | $-1,760 | $-3,640 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,970 | 5,309 | 176 | 450 | 2,870 |
| Financing Cash Flow | $3,970 | $5,309 | $176 | $450 | $2,870 |
| Beginning Cash Position | 350 | 28 | 32 | 170 | 230 |
| End Cash Position | 110 | 353 | 28 | 30 | 170 |
| Net Cash Flow | $-230 | $325 | $-4 | $-130 | $-60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,820 | -6,453 | -420 | 1,170 | 700 |
| Free Cash Flow | -3,820 | -6,453 | -420 | 1,170 | 700 |